Premium
Vascular endothelial growth factor inhibition for proliferative diabetic retinopathy: Et tu, Brute?
Author(s) -
Grauslund Jakob
Publication year - 2017
Publication title -
acta ophthalmologica
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/aos.13562
Subject(s) - diabetic retinopathy , medicine , ophthalmology , blindness , ranibizumab , diabetes mellitus , bevacizumab , clinical trial , randomized controlled trial , retinopathy of prematurity , retinal , optometry , endocrinology , chemotherapy , pregnancy , biology , gestational age , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom